Epilepsy News and Research

Latest Epilepsy News and Research

Study combines CT and VBM to provide accurate picture of autistic brain

Study combines CT and VBM to provide accurate picture of autistic brain

Catalyst Pharmaceutical Partners, NIDA to jointly conduct Phase II(b) trial of CPP-109 for cocaine addiction

Catalyst Pharmaceutical Partners, NIDA to jointly conduct Phase II(b) trial of CPP-109 for cocaine addiction

2010 UCBeyond Scholarship Program launched to help students living with chronic illnesses

2010 UCBeyond Scholarship Program launched to help students living with chronic illnesses

Epilepsy patients who take Ginkgo products face increased risk of seizures: Report

Epilepsy patients who take Ginkgo products face increased risk of seizures: Report

Anticonvulsants increase suicide risk

Anticonvulsants increase suicide risk

First direct recording of mirror neurons in the brain

First direct recording of mirror neurons in the brain

New patient education video and guidebook for MS patients

New patient education video and guidebook for MS patients

AED Vimpat to be the subject of numerous studies and analyses at AAN meeting

AED Vimpat to be the subject of numerous studies and analyses at AAN meeting

Catalyst Pharmaceutical Partners' vigabatrin data to be presented at 41st ASAM conference

Catalyst Pharmaceutical Partners' vigabatrin data to be presented at 41st ASAM conference

Telaprevir-based regimens increase rates of SVR in patients with genotype 1 HCV infection

Telaprevir-based regimens increase rates of SVR in patients with genotype 1 HCV infection

Smoking may increase risk of MS in people who have established risk factors for MS

Smoking may increase risk of MS in people who have established risk factors for MS

Children with FASD show high prevalence of developing epilepsy

Children with FASD show high prevalence of developing epilepsy

USPTO issues patent for Taro Pharmaceutical Industries' T2007

USPTO issues patent for Taro Pharmaceutical Industries' T2007

Strong demand leads to 5.1% growth in 2009 U.S. sales of ethical pharmaceuticals

Strong demand leads to 5.1% growth in 2009 U.S. sales of ethical pharmaceuticals

Catalyst Pharmaceutical Partners reports net loss of $7.24M for fourth-quarter 2009

Catalyst Pharmaceutical Partners reports net loss of $7.24M for fourth-quarter 2009

Eisai Europe seeks EMA approval of eribulin mesylate for locally advanced or metastatic breast cancer

Eisai Europe seeks EMA approval of eribulin mesylate for locally advanced or metastatic breast cancer

PhRMA report: 234 medicines in development for special health care needs of children

PhRMA report: 234 medicines in development for special health care needs of children

Loss of physical, psychological function after traumatic brain injury not related to injuries in brain structures

Loss of physical, psychological function after traumatic brain injury not related to injuries in brain structures

AAN awards 2010 Dreifuss-Penry Epilepsy Award to Vanderbilt University School of Medicine researcher

AAN awards 2010 Dreifuss-Penry Epilepsy Award to Vanderbilt University School of Medicine researcher

Eisai seeks simultaneous approval of eribulin mesylate in U.S., EU and Japan

Eisai seeks simultaneous approval of eribulin mesylate in U.S., EU and Japan

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.